Oncimmune Holdings PLC (AIM:ONC), the pharmaceutical company, confirmed new chief executive officer Martin Gouldstone has started his work at the group as well as joining the board of directors.
Gouldstone replaces Ron Kirschner, who will now take over as chief operating officer.